Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

Gulibahaer Ainiding; Ken Ichiro Yamashita; Takako Torii; Konosuke Furuta; Noriko Isobe; Takuya Matsushita; Katsuhisa Masaki; Shoji Matsumoto; Jun Ichi Kira

doi:10.1016/j.jneuroim.2012.03.009

Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

Gulibahaer Ainiding, Ken Ichiro Yamashita, Takako Torii, Konosuke Furuta, Noriko Isobe, Takuya Matsushita, Katsuhisa Masaki, Shoji Matsumoto, Jun Ichi Kira

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

Original language	English
Pages (from-to)	108-112
Number of pages	5
Journal	Journal of Neuroimmunology
Volume	246
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2012.03.009
Publication status	Published - 15-05-2012
Externally published	Yes

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Neurology
Clinical Neurology

Access to Document

10.1016/j.jneuroim.2012.03.009

Cite this

@article{f8fdc3d960ff48f0a668b7084f175ddb,

title = "Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis",

abstract = "We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.",

author = "Gulibahaer Ainiding and Yamashita, {Ken Ichiro} and Takako Torii and Konosuke Furuta and Noriko Isobe and Takuya Matsushita and Katsuhisa Masaki and Shoji Matsumoto and Kira, {Jun Ichi}",

note = "Funding Information: This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases ( H22-Nanchi-Ippan-130 ) from the Ministry of Health, Labour and Welfare , Japan.",

year = "2012",

month = may,

day = "15",

doi = "10.1016/j.jneuroim.2012.03.009",

language = "English",

volume = "246",

pages = "108--112",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier B.V.",

number = "1-2",

}

TY - JOUR

T1 - Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

AU - Ainiding, Gulibahaer

AU - Yamashita, Ken Ichiro

AU - Torii, Takako

AU - Furuta, Konosuke

AU - Isobe, Noriko

AU - Matsushita, Takuya

AU - Masaki, Katsuhisa

AU - Matsumoto, Shoji

AU - Kira, Jun Ichi

N1 - Funding Information: This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases ( H22-Nanchi-Ippan-130 ) from the Ministry of Health, Labour and Welfare , Japan.

PY - 2012/5/15

Y1 - 2012/5/15

N2 - We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

AB - We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

UR - http://www.scopus.com/inward/record.url?scp=84860212572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860212572&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2012.03.009

DO - 10.1016/j.jneuroim.2012.03.009

M3 - Article

C2 - 22484027

AN - SCOPUS:84860212572

SN - 0165-5728

VL - 246

SP - 108

EP - 112

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -

Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this